Abstract

Rosuvastatin 20-mg/5-mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2019 - Volume 23, Number 2

Page(s): 152

Download in electronic PDF format for $75
  • Rosuvastatin 20-mg/5-mL Oral Suspension Page 1

Note: Electronic version includes errata or revisions.

Abstract

A formulation for preparing Rosuvastatin 20-mg/5-mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist. NOTE: This formulation replaces the original Rosuvastatin 20 mg/mL Oral Suspension formula due to corrections made to original sources. Please see note under references for further information.

Related Keywords

  • rosuvastatin
  • formulation
  • statin drug
  • hyperlipidemia
  • high cholesterol
  • antihyperlipidemic agent
  • lipid disorders

Related Categories

  • FORMULATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2019
Pg. 152
Rosuvastatin 20-mg/5-mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 232
Atorvastatin 10-mg or 20-mg Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 420
Sorafenib 20-mg/mL in Oil Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 151
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 506
Thioguanine 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 294-300
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 55
Amoxicillin 125-mg/5-mL and 250-mg/5-mL Suspensions
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 220-228
Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 239
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 53
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 233
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 488
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 326
Acyclovir 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 243
Clozapine 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F